Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Estrogen Agonist/Antagonist [EPC]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Drug	Reports	Deaths	Death Rate	Hosp.	Life-Threat.	Avg Age	% Female
TAMOXIFEN	9,105	811	8.9%	1,754	319	55.6 yrs	95.6%
RALOXIFENE	4,185	34	0.8%	346	27	67.7 yrs	99.7%
OSPEMIFENE	2,047	2	0.1%	60	20	61.7 yrs	99.8%
CLOMIPHENE	686	27	3.9%	195	40	36.2 yrs	66.6%
TOREMIFENE	245	16	6.5%	92	14	61.7 yrs	95.0%

Head-to-Head Comparisons

TAMOXIFEN vs RALOXIFENE TAMOXIFEN vs OSPEMIFENE TAMOXIFEN vs CLOMIPHENE TAMOXIFEN vs TOREMIFENE RALOXIFENE vs OSPEMIFENE RALOXIFENE vs CLOMIPHENE RALOXIFENE vs TOREMIFENE OSPEMIFENE vs CLOMIPHENE OSPEMIFENE vs TOREMIFENE CLOMIPHENE vs TOREMIFENE

← Back to Estrogen Agonist/Antagonist [EPC] Class side effects →